battendiseasenews.com
Animal models predicted dosing of the enzyme replacement therapy Brineura
(cerliponase alfa) for patients with late infantile Batten disease, also called
CLN2 disease, a study showed. Scientists said this approach also may be applied
to predict cross-species dosing for other similar medicines...
over 3 years ago